| Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery S Vilar, G Cozza, S Moro Current topics in medicinal chemistry 8 (18), 1555-1572, 2008 | 1285 | 2008 |
| Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview V Salmaso, S Moro Frontiers in pharmacology 9, 923, 2018 | 822 | 2018 |
| FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination S Dupont, A Mamidi, M Cordenonsi, M Montagner, L Zacchigna, ... Cell 136 (1), 123-135, 2009 | 657 | 2009 |
| ADP receptors of platelets and their inhibition C Gachet Thrombosis and haemostasis 86 (07), 222-232, 2001 | 588 | 2001 |
| The mitochondrial calcium uniporter is a multimer that can include a dominant‐negative pore‐forming subunit A Raffaello, D De Stefani, D Sabbadin, E Teardo, G Merli, A Picard, ... The EMBO journal 32 (17), 2362-2376, 2013 | 580 | 2013 |
| Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway M Zusso, V Lunardi, D Franceschini, A Pagetta, R Lo, S Stifani, AC Frigo, ... Journal of neuroinflammation 16 (1), 148, 2019 | 564 | 2019 |
| Synthesis, CoMFA analysis, and receptor docking of 3, 5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists AH Li, S Moro, N Forsyth, N Melman, X Ji, KA Jacobson Journal of medicinal chemistry 42 (4), 706-721, 1999 | 275 | 1999 |
| DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites E Soldaini, S John, S Moro, J Bollenbacher, U Schindler, WJ Leonard Molecular and cellular biology 20 (1), 389-401, 2000 | 271 | 2000 |
| USP15 is a deubiquitylating enzyme for receptor-activated SMADs M Inui, A Manfrin, A Mamidi, G Martello, L Morsut, S Soligo, E Enzo, ... Nature cell biology 13 (11), 1368-1375, 2011 | 239 | 2011 |
| Toward the rational design of protein kinase casein kinase-2 inhibitors S Sarno, S Moro, F Meggio, G Zagotto, D Dal Ben, P Ghisellini, ... Pharmacology & therapeutics 93 (2-3), 159-168, 2002 | 220 | 2002 |
| Progress in the pursuit of therapeutic adenosine receptor antagonists S Moro, ZG Gao, KA Jacobson, G Spalluto Medicinal research reviews 26 (2), 131-159, 2006 | 217 | 2006 |
| Human P2Y1 Receptor: Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition Sites S Moro, D Guo, E Camaioni, JL Boyer, TK Harden, KA Jacobson Journal of medicinal chemistry 41 (9), 1456-1466, 1998 | 203 | 1998 |
| Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 G Cozza, M Mazzorana, E Papinutto, J Bain, M Elliott, G Di Maira, ... Biochemical Journal 421 (3), 387-395, 2009 | 197 | 2009 |
| Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application G Cozza, P Bonvini, E Zorzi, G Poletto, MA Pagano, S Sarno, ... Journal of medicinal chemistry 49 (8), 2363-2366, 2006 | 194 | 2006 |
| Hemolytic effects of water-soluble fullerene derivatives S Bosi, L Feruglio, T Da Ros, G Spalluto, B Gregoretti, M Terdoslavich, ... Journal of medicinal chemistry 47 (27), 6711-6715, 2004 | 189 | 2004 |
| Species diversity, taxonomy and distribution of Chondrichthyes in the Mediterranean and Black Sea F Serena, AJ Abella, F Bargnesi, M Barone, F Colloca, F Ferretti, ... The European Zoological Journal 87 (1), 497-536, 2020 | 186 | 2020 |
| The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes C Hoffmann, S Moro, RA Nicholas, TK Harden, KA Jacobson Journal of Biological Chemistry 274 (21), 14639-14647, 1999 | 181 | 1999 |
| Structure−Activity Relationships and Molecular Modeling of 3,5-Diacyl-2,4-dialkylpyridine Derivatives as Selective A3 Adenosine Receptor Antagonists AH Li, S Moro, N Melman, X Ji, KA Jacobson Journal of medicinal chemistry 41 (17), 3186-3201, 1998 | 181 | 1998 |
| Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure–activity relationships A Chilin, R Battistutta, A Bortolato, G Cozza, S Zanatta, G Poletto, ... Journal of medicinal chemistry 51 (4), 752-759, 2008 | 175 | 2008 |
| Role of the Extracellular Loops of G Protein-Coupled Receptors in Ligand Recognition: A Molecular Modeling Study of the Human P2Y1 Receptor S Moro, C Hoffmann, KA Jacobson Biochemistry 38 (12), 3498-3507, 1999 | 162 | 1999 |
Mattia SturleseDipartimento di Scienze del FarmacoVerified email at unipd.it
